EDR

EDROPHONIUM ION

Created:	1999-07-08
Last modified:	2011-06-04

Find Related PDB Entry
2 entries where EDR is found as a standalone ligand

Help Find related ligands:
Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Help

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	1
Atom Count	28
Chiral Atom Count	0
Bond Count	28
Aromatic Bond Count	6

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	EDROPHONIUM ION
Systematic Name (OpenEye OEToolkits)	ethyl-(3-hydroxyphenyl)-dimethyl-azanium
Formula	C₁₀ H₁₆ N O
Molecular Weight	166.24
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	Oc1cccc(c1)[N+](C)(CC)C
SMILES	CACTVS	3.341	CC[N+](C)(C)c1cccc(O)c1
SMILES	OpenEye OEToolkits	1.5.0	CC[N+](C)(C)c1cccc(c1)O
Canonical SMILES	CACTVS	3.341	CC[N+](C)(C)c1cccc(O)c1
Canonical SMILES	OpenEye OEToolkits	1.5.0	CC[N+](C)(C)c1cccc(c1)O
InChI	InChI	1.03	InChI=1S/C10H15NO/c1-4-11(2,3)9-6-5-7-10(12)8-9/h5-8H,4H2,1-3H3/p+1
InChIKey	InChI	1.03	VWLHWLSRQJQWRG-UHFFFAOYSA-O

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB01010
Name	Edrophonium
Groups	approved
Description	A rapid-onset, short-acting cholinesterase inhibitor used in cardiac arrhythmias and in the diagnosis of myasthenia gravis. It has also been used as an antidote to curare principles.
Synonyms	Ethyl-(3-hydroxy-phenyl)-dimethyl-ammonium N-ethyl-3-hydroxy-N,N-dimethylanilinium Edrophonium Edrophonium ion 3-hydroxy-N,N-dimethyl-N-ethylanilinium Edrophonium bromide Edrophonium cation N-ethyl-3-hydroxy-N,N-dimethylbenzenaminium Edrophonium chloride (3-hydroxyphenyl)dimethylethylammonium
Brand Names	Enlon-Plus Enlon Enlon Plus Enlon 10mg/ml Enlon Liq IV 10mg/ml Tensilon
Indication	For the differential diagnosis of myasthenia gravis and as an adjunct in the evaluation of treatment requirements in this disease. It may also be used for evaluating emergency treatment in myasthenic crises.
Categories	Amines Antidotes Cholinergic Agents Cholinesterase Inhibitors Compounds used in a research, industrial, or household setting Diagnostic Agents Drugs that are Mainly Renally Excreted Enzyme Inhibitors Neurotransmitter Agents Onium Compounds Phenylammonium Compounds Protective Agents Quaternary Ammonium Compounds
ATC-Code	V04CX07
CAS number	312-48-1

Drug Targets

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

Name	Target Sequence	Pharmacological Action	Actions
Cholinesterase	MHSKVTIICIRFLFWFLLLCMLIGKSHTEDDIIIATKNGKVRGMNLTVFG...	unknown	inhibitor
Acetylcholinesterase	MRPPQCLLHTPSLASPLLLLLLWLLGGGVGAEGREDAELLVTVRGGRLRG...	unknown	inhibitor

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682